Table 1.
Summary of the used dataset.
| Index | Cancer type | Sample size |
|---|---|---|
| 1 | Bladder urothelial carcinoma (BLCA) | 249 |
| 2 | Breast invasive carcinoma (BRCA) | 837 |
| 3 | Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) | 191 |
| 4 | Glioblastoma multiforme (GBM) | 152 |
| 5 | Head and neck squamous cell carcinoma (HNSC) | 422 |
| 6 | Kidney chromophobe (KICH) | 66 |
| 7 | Kidney renal clear cell carcinoma (KIRC) | 446 |
| 8 | Kidney renal papillary cell carcinoma (KIRP) | 195 |
| 9 | Brain lower-grade glioma (LGG) | 486 |
| 10 | Liver hepatocellular carcinoma (LIHC) | 183 |
| 11 | Lung adenocarcinoma (LUAD) | 486 |
| 12 | Lung squamous cell carcinoma (LUSC) | 220 |
| 13 | Ovarian serous cystadenocarcinoma (OV) | 407 |
| 14 | Prostate adenocarcinoma (PRAD) | 370 |
| 15 | Skin cutaneous melanoma (SKCM) | 225 |
| 16 | Stomach adenocarcinoma (STAD) | 282 |
| 17 | Thyroid carcinoma (THCA) | 492 |